WTR Biotech Spotlight
WTR Biotech Spotlight is a biweekly conversation with biotech executives, medical experts, and investors on recent clinical data or industry-driving events in biotech.
Podcasting since 2025 • 7 episodes
WTR Biotech Spotlight
Latest Episodes
Most-Favored-Nation Drug Pricing Lacks Executive Plan
Tim Gerdeman and Do Kim discuss President Trump’s executive order on lowering drug prices through Most-Favored-Nation reference pricing. They talk about the goal of the executive order and whether the government has the authority for price-sett...
•
Season 2
•
Episode 7
•
9:09
Current State of Biotech, Market Pressure Points, Obesity and PD-1/VEGF
Tim Gerdeman and Do Kim discuss the current state of biotech, what brought us here, and how the rest of year may look for the group. They also review recent market-shaping events in the obesity space and progress of the Keytruda-busting PD-1/VE...
•
Season 1
•
Episode 6
•
18:59
WTR Biotech Flashcast: Neuroscience, Alzheimer’s and Biogen IOC
On this week's episode of WTR Biotech Spotlight, Tim Gerdeman and Robert Sassoon sit down for a quick flashcast to review Robert's last three reports; Neuroscience, Alzheimer’s and Biogen IOC.
•
Season 1
•
Episode 5
•
16:01
Annovis Bio's CEO Discusses the promise of Buntanetap in Redefining the Treatment of Alzheimer's and Parkinson's and Next Steps
Founding CEO and President of Annovis Bio (NYSE: ANVS) Dr Maria Maccecchini joins WTR's Tim Gerdeman and Robert Sassoon in this week's WTR Biotech Spotlight episode. Annovis is a late clinical-stage drug platform company developing novel ...
•
Season 1
•
Episode 4
•
18:23
Veru, Inc. CEO Mitch Steiner Discusses Recent Enobosarm Data and Preserving Muscle While on GLP-1 Obesity Drugs
CEO Mitch Steiner joins us on this week’s WTR Biotech Spotlight to talk about the next generation of drugs focusing on lean mass (muscle) preservation for obesity patients on the popular GLP-1 therapies. He reviews the recent enobosarm Phase 2b...
•
Season 1
•
Episode 3
•
34:32